Start Submission Become a Reviewer

Reading: Health economics of cardiovascular disease: Defining the research agenda

Download

A- A+
Alt. Display

Research

Health economics of cardiovascular disease: Defining the research agenda

Authors:

Keith C. Ferdinand ,

Association of Black Cardiologists, Inc., Emory University, 5355 Hunter Road, Atlanta, GA 30349, US
X close

Diane Orenstein,

Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention, Applied Research and Evaluation Branch, 4770 Buford Highway, North East, Mailstop K-47, Atlanta, GA 30341, US
About Diane
The findings and conclusions in this report are those of CDC authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
X close

Yuling Hong,

Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention, Applied Research and Evaluation Branch, 4770 Buford Highway, North East, Mailstop K-47, Atlanta, GA 30341, US
About Yuling
The findings and conclusions in this report are those of CDC authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
X close

Joann G. Journigan,

Emory University Carilion Clinic Cardiology, 127 McClanahan Street, Suite 300, Roanoke, VA 24014, US
X close

Justin Trogdon,

RTI International, 3040 Cornwallis Road, Hobbs Building, Research Triangle Park, NC 27709, US
X close

Jennifer Bowman,

Avalere Health, 1350 Connecticut Avenue, Suite 900, Washington, DC 20036, US
X close

Armineh Zohrabian,

Cancer Care Ontario, Formerly with Centers for Disease, Control and Prevention, Pharmacoeconomics Research Unit, Cancer Care Ontario, 620 University Avenue, Suite 1500, Toronto, Ontario, M5G 2L7, CA
X close

Meredith Kilgore,

University of Alabama at Birmingham, Health Care Organization & Policy, RPHB 330, 1530 3rd Avenue South, Birmingham, AL 35294-0022, US
X close

Alexander White,

Heart Disease and Stroke Prevention Branch, North Carolina Division of Public Health, P.O. Box 487, Chapel Hill, NC 27514, US
X close

Ali Mokdad,

Institute for Health Metrics and Evaluation, University of Washington, Global Health, 2301 5th Avenue, Suite 600, Seattle, WA 98121, US
X close

Terry F. Pechacek,

Centers for Disease Control and Prevention, Mailstop K-50, 4770 Buford Highway, NE, Atlanta, GA 30341, US
About Terry F.
The findings and conclusions in this report are those of CDC authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
X close

Ron Z. Goetzel,

Rollins School of Public Health, Emory University and Thomson Reuters, 4301 Connecticut Avenue, NW, Suite 330, Washington, DC 20008, US
About Ron Z.
The findings and conclusions in this report are those of CDC authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
X close

Darwin R. Labarthe,

Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention, Applied Research and Evaluation Branch, 4770 Buford Highway, North East, Mailstop K-47, Atlanta, GA 30341, US
X close

Gary A. Puckrein,

National Minority Quality Forum, 1200 New Hampshire Avenue, NW, Suite 575, Washington, DC 20036, US
X close

Eric Finkelstein,

Duke-NUS Graduate Medical School, Singapore, Formerly with RTI International, 8 College Road, Singapore 169857, SG
X close

Guijing Wang,

Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention, Applied Research and Evaluation Branch, 4770 Buford Highway, North East, Mailstop K-47, Atlanta, GA 30341, US
About Guijing
The findings and conclusions in this report are those of CDC authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
X close

Molly E. French,

Potomac Health Consulting, 6122 11th Road N, Arlington, VA 22205, US
X close

Viola Vaccarino

Emory University, 1518 Clifton Road, NE, Room 3011, Atlanta, GA 30322, US
X close

Abstract

Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data.

Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda.

Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.

How to Cite: Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, et al.. Health economics of cardiovascular disease: Defining the research agenda. Global Heart. 2011;6(3):91–100. DOI: http://doi.org/10.1016/j.cvdpc.2011.05.001
1
Views
2
Downloads
Published on 01 Sep 2011.

Downloads

  • PDF (EN)

    comments powered by Disqus